News | News By Subject | News by Disease News By Date | Search News

Prostate cancer News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Massachusetts’ Cellanyx Develops New Method to Culture Primary Prostate Cells     6/2/2017
Pfizer (PFE)'s Xtandi Flunks Late-Stage Study Against Johnson & Johnson (JNJ)'s Zytiga     12/16/2016
Taking a Closer Look at Nymox (NYMX)'s 'Overinflated' Prostate Drug Hype     8/29/2016
Struggling Tokai Pharma (TKAI) Nixes Enrollment in Mid-Stage Prostate Cancer Study     8/23/2016
Tokai Pharma (TKAI) Axes 60% of Workforce After Phase III Prostate Cancer Trial Failure     8/1/2016
Tokai Pharma (TKAI) to Terminate ARMOR3-SV Clinical Trial, Shares Tank     7/26/2016
ANI Pharma Snags FDA Approval and Immediate Launch of Nilutamide Tablets, The First Generic Competitor to Nilandron     7/18/2016
UCLA Sells Royalty Rights Connected with Cancer Drug to Royalty Pharma for $1.14 Billion     3/7/2016
Eagle Pharma (EGRX), Teikoku Pharma Win FDA Approval of Docetaxel Injection, First and Only Alcohol-Free Formulation     12/28/2015
ASCO15: Exelixis (EXEL) Results for Drug Combo Buoy the Flailing SF Biotech     6/1/2015
Ipsen (IPN.PA), Active Biotech AB (BTPC) Plummet As Prostate Cancer Drug Flunks Late-Stage Trial     4/17/2015
Bristol-Myers Squibb (BMY) Bets $975 Million on Bavarian Nordic (BAVA.CO)'s Prostate Cancer Vaccine     3/5/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
ArQule, Inc. (ARQL) Reports Positive Phase 2 Tivantinib Prostate Cancer Trial Data     11/10/2014

News from Around the Web
New Three-In-One Blood Test Opens Door To Precision Medicine For Prostate Cancer, The Institute of Cancer Research Study Reveals     6/19/2017
New Blood Test Uses Nanotechnology To Predict Aggressive Prostate Cancer Accurately     6/12/2017
Why Johnson & Johnson (JNJ)'s New Prostate Cancer Drug Could Spell Trouble For Pfizer (PFE)     6/7/2017
Gazing Into The Crystal Ball For Advaxis (ADXS): What To Expect At ASCO 2017     4/7/2017
Guys: You Don't Want That PSA Test For Prostate Cancer     4/4/2017
'Sniffing' Urine To Detect Prostate Cancer Could Prevent Unnecessary Biopsies, Journal of Urology Reveals     4/3/2017
Old Drug Gets New Trick For Prostate Cancer Treatment, Massachusetts General Hospital Reveals     2/3/2017
University of Pennsylvania Study Links Prostate Cancer Treatment To Dementia     10/14/2016
Ben Stiller Reveals Prostate Cancer Diagnosis, Says PSA Test Saved His Life     10/5/2016
New Prostate Cancer Tests Aim To Reduce The Death Rate     10/4/2016
New Prostate Cancer Test Strives To Slash Biopsies, Cleveland Diagnostics Reveals     7/7/2016
Robotic Rectum May Aid Prostate Cancer Diagnosis, Imperial College London Study     7/5/2016
University of Alabama at Birmingham Receives Cutting-Edge Robot To Diagnose And Support Treatment Of Prostate Cancer     6/9/2016
University of Virginia Researchers Work to Speed Prostate Cancer Detection     6/6/2016
BMI And Waist Size Linked To Prostate Cancer Risk, University of Oxford Study Finds     6/3/2016

Press Releases
Angle Announces Parsortix Breakthrough Delivers Rare Blood Cell Discovery In Prostate Cancer     6/19/2017
Bavarian Nordic (BAVA.CO) Provides Update On Anticipated Timing Of PROSPECT Study     6/16/2017
Modra Pharma Announces Start Of Phase II Study For Its Lead Oral Chemotherapy In Patients With Metastatic Prostate Cancer     6/14/2017
Astellas (ALPMY) And Pfizer (PFE) Announce Amendment To Clinical Research Protocol For Phase III PROSPER Trial Of Enzalutamide In Patients With Non-Metastatic Castration-Resistant Prostate Cancer     6/9/2017
Sophiris Bio (SPHS) Announces That The First Patient Has Been Dosed In Phase IIb Study Of Topsalysin In Patients With Clinically Significant Localized Prostate Cancer     6/8/2017
Q Biomed Announces Commercialization Of Non-Narcotic Metastatic Cancer Pain Drug     6/8/2017
Aptevo Therapeutics (APVO) Highlights Key Features Of Its ADAPTIR Protein Therapeutic Platform At Two Industry Conferences     6/7/2017
GenomeDx Biosciences Release: Multiple Studies Further Validate The Importance Of Decipher Post-Op In The Treatment Of Prostate Cancer     6/7/2017
ESSA Pharma Presents Data From Phase I Trial Of EPI-506 At 2017 ASCO Annual Meeting     6/6/2017
Janssen-Cilag International NV (JNJ) Release: Abiraterone Acetate Provided Significant Clinical Benefit In Patients With High-Risk Metastatic Hormone-Naïve Prostate Cancer (mHNPC), Improving Overall Survival And Radiographic Progression-Free Survival     6/5/2017
NewLink Genetics (NLNK)’ Indoximod + PROVENGE Results In Statistically Significant Improvement In Radiographic Progression-Free Survival (rPFS) For Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) In Phase II Trial     6/5/2017
Invitae Release: ASCO Data Shows Prostate Cancer Patients With Genetic Risk Factors Missed Under Current Testing Guidelines     6/5/2017
Invitae Release: ASCO Data Shows Prostate Cancer Patients With Genetic Risk Factors Missed Under Current Testing Guidelines     6/5/2017
Progenics (PGNX) Announces The Presentation Of Data From Two Automated Bone Scan Index Studies At The 2017 ASCO Annual Meeting     6/2/2017
IBM (IBM) Release: At ASCO 2017 Clinicians Present New Evidence About Watson Cognitive Technology And Cancer Care     6/1/2017

//-->